The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Fateeva O.V.

Lipetsk Municipal Polyclinic N 2

Kozhevnikova S.A.

Voronezh State Medical University named after N.N. Burdenko

Prozorova G.G.

Voronezh State Medical University named after N.N. Burdenko

Prognostic factors for progression and risk chronic obstructive pulmonary disease adverse outcomes

Authors:

Fateeva O.V., Kozhevnikova S.A., Prozorova G.G.

More about the authors

Journal: Journal of Respiratory Medicine. 2025;1(2): 71‑78

Read: 1306 times


To cite this article:

Fateeva OV, Kozhevnikova SA, Prozorova GG. Prognostic factors for progression and risk chronic obstructive pulmonary disease adverse outcomes. Journal of Respiratory Medicine. 2025;1(2):71‑78. (In Russ.)
https://doi.org/10.17116/respmed2025102171

Recommended articles:
Endo­vascular treatment and sele­ction criteria for acute mese­nteric ischemia. Piro­gov Russian Journal of Surgery. 2025;(2):13-19
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Follow-up care in the Russian Fede­ration: Trends of indi­cators. Russian Journal of Preventive Medi­cine. 2025;(2):13-18
Possibilities of vibroacoustic therapy application in patients with chro­nic bronchopulmonary pathology. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):12-18
Effi­cacy of dupi­lumab application in bullous pemphigoid proceeding in presence of bronchial asthma. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):204-209

References:

  1. Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227-2242. https://doi.org/10.1016/S0140-6736(22)00470-6
  2. Safiri S, Carson-Chahhoud K, Noori M, Nejadghaderi SA, Sullman MJM, Ahmadian Heris J, Ansarin K, Mansournia MA, Collins GS, Kolahi AA, Kaufman JS. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022;378:e069679. https://doi.org/10.1136/bmj-2021-069679
  3. Kahnert K, Jörres RA, Behr J, Welte T. The Diagnosis and Treatment of COPD and Its Comorbidities. Dtsch Arztebl Int. 2023;120(25):434-444.  https://doi.org/10.3238/arztebl.m2023.027
  4. Prozorova GG, Agapova YuR, Fateeva OV, Tribuntseva LV. Influence of comorbidity on the course of chronic obstructive pulmonary disease. Nauchno-medicinskij vestnik Central’nogo Chernozem’ya. 2022;93:122-130. (In Russ.). https://doi.org/10.18565/therapy.2021.8.38-45
  5. Alter P, Mayerhofer BA, Kahnert K, Watz H, Waschki B, Andreas S, Biertz F, Bals R, Vogelmeier CF, Jörres RA. Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort. Int J Chron Obstruct Pulmon Dis. 2019;14:2163-2172. https://doi.org/10.2147/COPD.S209343
  6. Trudzinski FC, Kellerer C, Jörres RA, Alter P, Lutter JI, Trinkmann F, Herth FJF, Frankenberger M, Watz H, Vogelmeier CF, Kauczor HU, Welte T, Behr J, Bals R, Kahnert K. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities. Clin Res Cardiol. 2023;112(2):177-186.  https://doi.org/10.1007/s00392-021-01915-x
  7. Wang JJ. Risk of coronary heart disease in people with chronic obstructive pulmonary disease: a meta-analysis. Int J Chron Obstruct Pulmon Dis. 2021;16:2939-2944.
  8. Kaszuba M, Śliwka A, Piliński R, Kościelniak J, Maga P, Bochenek G, Nowobilski R. The Comorbidity of Chronic Obstructive Pulmonary Disease and Peripheral Artery Disease ‒ A Systematic Review. COPD. 2019;16(3-4):292-302.  https://doi.org/:10.1080/15412555.2019.1653271
  9. Ignatova GL, Blinova EV, Antonov VN. Analysis of Adverse Outcome Factors in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Diabetes Mellitus: 10-Year Follow-up Results. Therapy. 2021;8:38-45. (In Russ.). https://doi.org/10.18565/therapy.2021.8.38-45
  10. Park SS, Perez Perez JL, Perez Gandara B, Agudelo CW, Rodriguez Ortega R, Ahmed H, Garcia-Arcos I, McCarthy C, Geraghty P. Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD? Medicina (Kaunas). 2022;58(8):1030. https://doi.org/10.3390/medicina58081030
  11. Qi C, Sun SW, Xiong XZ. From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis. Int J Chron Obstruct Pulmon Dis. 2022;17:2603-2621. https://doi.org/10.2147/COPD.S380732
  12. Karoli NA, Borodkin AV, Rebrov AP. Risk factors for adverse outcomes in patients with chronic obstructive pulmonary disease. Therapy. 2022;5:18-25. (In Russ.). https://doi.org/10.18565/therapy.2022.5.18-25
  13. Chronic obstructive pulmonary disease: clinical guidelines. Accessed April 14, 2025. (In Russ.). https://cr.minzdrav.gov.ru/schema/603_2
  14. Global Strategy for Diagnosis, Management and Prevention of COPD: 2021. Global Initiative for Obstructive Lung Disease. Accessed April 14,2025. https://goldcopd.org/2022-gold-reports
  15. Abduganieva EA, Liverko IV, Gafner NV. Circulatory diseases as the leading cause of death in patients with chronic obstructive pulmonary disease. Eurasian Heart Journal. 2019;1:362-363. (In Russ.).
  16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A New Method of Classifying Prognostic Comorbidity in Longitudinal Studies: Development and Validation. Journal of Chronic Diseases. 1987;40:373-383. 
  17. Mei F, Dalmartello M, Bonifazi M, Bertuccio P, Levi F, Boffetta P, Negri E, La Vecchia C, Malvezzi M. Chronic obstructive pulmonary disease (COPD) mortality trends worldwide: An update to 2019. Respirology. 2022;27(11):941-950.  https://doi.org/10.1111/resp.14328
  18. Xiong W, Du H, Xu M, Ding W, Sun J, Han F, Guo X. An authoritative algorithm most appropriate for the prediction of pulmonary embolism in patients with AECOPD. Respir Res. 2020;21(1):218.  https://doi.org/10.1186/s12931-020-01483-0

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.